Share Your Content with Us
on TradePub.com for readers like you. LEARN MORE
Use of Metabolomics to Phenotype and Categorize Risk in Human Health Studies Accelerates Clinical Care and Drug Development

Request Your Free Research Report Now:

"Use of Metabolomics to Phenotype and Categorize Risk in Human Health Studies Accelerates Clinical Care and Drug Development"

Presented at: Gordon Research Conference -- Metabolomics and Human Health March 12-15, 2023

Nontargeted metabolomics and both genome-wide association study (GWAS) and whole genome sequencing (WGS) approaches were used to identify genetic variants that modify the blood metabolome to identify signatures of human disease.

Authors: Gregory A. Michelotti, Silvia Grant, Patricia Sheridan


Offered Free by: Metabolon
See All Resources from: Metabolon

Recommended for Professionals Like You:

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.